Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
03/2014
03/19/2014CN103638043A Pharmaceutical composition containing deproteinated extract of calf blood and preparation method thereof
03/19/2014CN103638035A Application of polydatin for preparing medicament for treating atherosclerosis
03/19/2014CN103638034A Application of morindae officinalis oligosaccharide pentasaccharide to preparation of drug for treating myocardial ischemia and reperfusion injury
03/19/2014CN103638023A Application of penehyclidine hydrochloride in treatment of microcirculation disturbance caused by toxic shock infection after comprehensive treatment measures such as supplementing blood volume and the like
03/19/2014CN103638017A Composition of ginkgolide A and ginkgolide B and application of composition
03/19/2014CN103638012A Application of Myrtucommuacetalone in medicine for treatment of myocardial ischemia
03/19/2014CN103638003A Compositions rich in N-acylethanolamides
03/19/2014CN103637999A Multi-layer solid drug dosage form
03/19/2014CN103637985A Stable PGE1 lyophilized emulsion and preparation method thereof
03/19/2014CN103637983A Pharmaceutical composition containing Nalmefene hydrochloride and preparation method of pharmaceutical composition
03/19/2014CN103637608A Hypertensive healthcare drug pillow
03/19/2014CN103637607A Hypertensive healthcare drug pillow
03/19/2014CN103637606A Hypertensive healthcare drug pillow
03/19/2014CN103637605A Hypertensive healthcare drug pillow
03/19/2014CN103637604A Hypertensive healthcare drug pillow
03/19/2014CN103637193A Nourishing and conditioning composition
03/19/2014CN103637102A A supplement
03/19/2014CN103636848A Chinese olive and mint tea
03/19/2014CN103636833A Health tea able to reduce blood lipid
03/19/2014CN103239723B Compound antihypertensive agent
03/19/2014CN103142986B Medicine for treating arrhythmia
03/19/2014CN103127018B Levamlodipine besylate tablet and preparation method thereof
03/19/2014CN103083267B Polysaccharide sulfate chewable tablet
03/19/2014CN103083261B Polysaccharide sulfate freeze-dried powder injection
03/19/2014CN103052632B Dihydropyrazole Compounds
03/19/2014CN102940757B Medicine composition for treating diabetic foot
03/19/2014CN102824551B Traditional Chinese medicine for treating Raynaud disease and processing technology for traditional Chinese medicine
03/19/2014CN102787155B Preparation method of yak milk casein antihypertensive peptide
03/19/2014CN102764380B Traditional Chinese medicine composite for curing cerebrovascular disease sequelae
03/19/2014CN102697963B Traditional Chinese medicine composition for curing Raynaud's disease
03/19/2014CN102676621B Antihypertensive rapeseed peptide and preparation method and application of antihypertensive rapeseed peptide
03/19/2014CN102552621B Drug combination for treating cardiovascular diseases and preparation method and application of same
03/19/2014CN102406911B Chinese medicine preparation for treating coronary heart disease
03/19/2014CN102366419B Application of rutin in preparation of antihypoxic medicaments
03/19/2014CN102038864B Application of Chinese medicinal composition in preparation of medicament for treating diabetic cardiomyopathy
03/19/2014CN102018212B Red yeast rice capsules and preparation method thereof
03/19/2014CN101987112B Medicine composition for treating cardio-cerebrovascular diseases and preparation method thereof
03/18/2014US8673946 4-trimethylammonio-butyrates as CPT2 inhibitors
03/18/2014US8673934 Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident
03/18/2014US8673921 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
03/18/2014US8673917 2-heteroaryl-pyrrolo [3,4-C]pyrrole derivatives, and use thereof as SCD inhibitors
03/18/2014US8673892 Phenyl bicyclic methyl azetidine derivatives as sphingosine-1 phosphate receptors modulators
03/18/2014US8673889 BLT2-mediated disease, BLT2 binding agent and the compound
03/18/2014US8673854 Prophylactic agent for heart failure
03/18/2014US8673847 Peptide based peroxidase inhibitors and methods of using same
03/18/2014US8673586 Compounds that interact with kinases
03/18/2014US8673305 Methods of treatment with antibodies against the extracellular loops of C5aR
03/18/2014US8673266 Polyvinyl alcohol microspheres, injectable solutions and therapeutic uses of the same
03/18/2014CA2768682C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
03/18/2014CA2767061C Specific binding agents of human angiopoietin-2
03/18/2014CA2700526C New compounds as adenosine a1 receptor antagonists
03/18/2014CA2682596C Use of carboxyamidotriazole (cai) orotate in macular degeneration
03/18/2014CA2652826C A composition comprising extracts of radix ginseng, folium ginkgo, stigma croci and glycine max and use thereof for treating ischemic cerebrovascular disease
03/18/2014CA2647677C Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
03/13/2014WO2014039859A1 Diagnostic markers for platelet function and methods of use
03/13/2014WO2014039434A1 Alkoxy pyrazoles as soluble guanylate cyclase activators
03/13/2014WO2014038686A1 Adsorbent
03/13/2014WO2014037863A1 Methods for prevention and treatment of preeclampsia
03/13/2014WO2014037186A1 Laser configuration that reduces the laser footprint and improves ergonomics
03/13/2014WO2014036821A1 Novel compound with effects of thrombolysis, free radical scavenging and thrombus-targeting as well as preparation method and use thereof
03/13/2014WO2014036603A1 Uses of (-)-perhexiline
03/13/2014WO2014011895A3 High solubility acid salts, intravenous dosage forms, nutrition supplementation and methods of use thereof
03/13/2014US20140073692 Highly purified ethyl epa and other epa derivatives
03/13/2014US20140073677 Valsartan salts
03/13/2014US20140073596 N-Pyrazole A2A Receptor Agonists
03/13/2014US20140073046 Cell Populations Which Co-Express CD49C and CD90
03/13/2014US20140072646 Thyroid hormone analogs and methods of use
03/12/2014EP2706113A1 Synthetic peptide capable of inducing expression of type-2 tnf receptor and use thereof
03/12/2014CN103635195A Prostacyclin and analogs thereof administered during surgery for prevention and treatment of capillary leakage
03/12/2014CN103635184A Soyasapogenol composition
03/12/2014CN103627748A Preparation method of indirubin derivative and product and application thereof
03/12/2014CN103627671A Method for generating endoderm and mesoderm lineages and multipotent migratory cells (MMC), and cell population and use
03/12/2014CN103627600A Maca healthcare wine and preparation method thereof
03/12/2014CN103627586A Health-care glutinous rice wine and preparation method thereof
03/12/2014CN103626865A Secreted protein with chemotactic activity, as well as coding sequence and medicament usage thereof
03/12/2014CN103626845A Arylpyrrole-2-formamide dipeptide derivatives serving as glycogen phosphorylase inhibitor and preparation method and medical application thereof
03/12/2014CN103626837A Glycogen phosphorylase inhibitor cholic acid derivative containing bio-cleavable dipeptide and preparation method and medical application thereof
03/12/2014CN103626826A Azo bond contained glycogen phosphorylase inhibitor cholic acid derivative and preparation method and medical application thereof
03/12/2014CN103626825A Liver-targeted glycogen phosphorylase inhibitor cholic acid derivative and preparation method and medical application thereof
03/12/2014CN103626812A Novel parishin compound in gastrodia elata and application of compound
03/12/2014CN103626801A Fostrecin (FST) derivative and medical application and preparation method thereof
03/12/2014CN103626800A Fostrecin (FST) derivative and medical application and preparation method thereof
03/12/2014CN103626783A Dicyclic fused heterocyclic compounds, and applications and pharmaceutical compositions thereof
03/12/2014CN103626777A PLK inhibitor salts
03/12/2014CN103626765A Substituted azaindole compound and salt, composition and application thereof
03/12/2014CN103626749A Substituted oxazolidinone compound, and pharmaceutical composition containing compound and application thereof
03/12/2014CN103626709A Ligustrazine phosphate compound and drug composition containing ligustrazine phosphate compound and ginkgo leaf effective ingredients
03/12/2014CN103626694A Unsaturated cyclic amine derivatives, preparation method and medical uses thereof
03/12/2014CN103623425A Medicament for inhibiting neovascularization diseases angiogenesis by using dual-target antagomir
03/12/2014CN103623408A Low dose methods for treating disorders in which tnf dollar g(a) activity is detrimental
03/12/2014CN103623396A Pharmaceutical composition containing recombinant tissue plasminogen activator
03/12/2014CN103623390A Glutamine for use in treating injury
03/12/2014CN103623378A Traditional Chinese medicine for treating thoraco-abdominal aorta type multiple aorto-arteritis
03/12/2014CN103623365A Externally-applied medicine for rapid cardiac first aid and preparation method thereof
03/12/2014CN103623361A Traditional Chinese medicine composition for treating cerebral thrombosis
03/12/2014CN103623352A Medication for treating cardiopalmus and preparation method thereof
03/12/2014CN103623351A Stroke rehabilitation revival pill and preparation method thereof
03/12/2014CN103623347A Traditional Chinese medicine for treating finger necrosis caused after rolling compaction wound of orthopaedic patient
03/12/2014CN103623341A Drug for treating hypertension and cardiovascular and cerebrovascular diseases caused by hypertension
03/12/2014CN103623326A Hypotensive, hypoglycemic and lipid lowering medicine
1 ... 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 ... 1595